SMS 201.995 (Sandostatin) enhances in-vitro effects of 5-Fluorouracil in colorectal cancer
- 28 February 1995
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 21 (1) , 27-32
- https://doi.org/10.1016/s0748-7983(05)80063-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.Gut, 1994
- MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapyEuropean Journal Of Cancer, 1992
- Drug Treatment of Colorectal CancerDrugs, 1991
- Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamstersInternational Journal of Cancer, 1991
- A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma.Journal of Clinical Oncology, 1991
- Failure of High-Dose Leucovorin To Improve Therapy With the Maximally Tolerated Dose of 5-Fluorouracil: A Murine Study With Clinical Relevance?JNCI Journal of the National Cancer Institute, 1988
- Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitroBritish Journal of Surgery, 1988
- Growth factors and intestinal neoplasmsThe American Journal of Surgery, 1988
- A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.Journal of Clinical Oncology, 1988
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979